UNDERSTANDING ADIPOCYTE HETEROGENEITY ACROSS SPECIES, DEPOT, AND DISEASE

Descargar Publicación
Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response? Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity